193 related articles for article (PubMed ID: 26383528)
1. LIM domain only 2 induces glioma invasion via cytosolic p27(KIP1).
Park CG; Sohn YW; Kim EJ; Kim SH; Kim SC; Kim H
Tumour Biol; 2016 Feb; 37(2):2473-80. PubMed ID: 26383528
[TBL] [Abstract][Full Text] [Related]
2. TRIP6 regulates p27 KIP1 to promote tumorigenesis.
Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT
Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869
[TBL] [Abstract][Full Text] [Related]
3. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
[TBL] [Abstract][Full Text] [Related]
4. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity.
Wu FY; Wang SE; Sanders ME; Shin I; Rojo F; Baselga J; Arteaga CL
Cancer Res; 2006 Feb; 66(4):2162-72. PubMed ID: 16489017
[TBL] [Abstract][Full Text] [Related]
5. Nrdp1-mediated ErbB3 degradation inhibits glioma cell migration and invasion by reducing cytoplasmic localization of p27(Kip1).
Shi H; Gong H; Cao K; Zou S; Zhu B; Bao H; Wu Y; Gao Y; Tang Y; Yu R
J Neurooncol; 2015 Sep; 124(3):357-64. PubMed ID: 26088461
[TBL] [Abstract][Full Text] [Related]
6. LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer.
Liu Y; Huang D; Wang Z; Wu C; Zhang Z; Wang D; Li Z; Zhu T; Yang S; Sun W
Sci Rep; 2016 Oct; 6():36050. PubMed ID: 27779255
[TBL] [Abstract][Full Text] [Related]
7. Progesterone induces RhoA Inactivation in male rat aortic smooth muscle cells through up-regulation of p27(kip1.).
Wang HC; Lee WS
Endocrinology; 2014 Nov; 155(11):4473-82. PubMed ID: 25137028
[TBL] [Abstract][Full Text] [Related]
8. Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF-κB signaling.
Li J; Xu H; Wang Q; Fu P; Huang T; Anas O; Zhao H; Xiong N
Cancer Med; 2019 May; 8(5):2288-2302. PubMed ID: 30848088
[TBL] [Abstract][Full Text] [Related]
9. Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27(KIP1) and MMP3 expression.
Jin X; Jin X; Sohn YW; Yin J; Kim SH; Joshi K; Nam DH; Nakano I; Kim H
Cancer Lett; 2013 Jan; 328(2):235-42. PubMed ID: 23022473
[TBL] [Abstract][Full Text] [Related]
10. Lmo2 (LIM-Domain-Only 2) Modulates Sphk1 (Sphingosine Kinase) and Promotes Endothelial Cell Migration.
Matrone G; Meng S; Gu Q; Lv J; Fang L; Chen K; Cooke JP
Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1860-1868. PubMed ID: 28775072
[TBL] [Abstract][Full Text] [Related]
11. LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling.
Liu Y; Wang Z; Huang D; Wu C; Li H; Zhang X; Meng B; Li Z; Zhu T; Yang S; Sun W
Oncotarget; 2017 Feb; 8(6):9513-9524. PubMed ID: 27880729
[TBL] [Abstract][Full Text] [Related]
12. p27Kip1 modulates cell migration through the regulation of RhoA activation.
Besson A; Gurian-West M; Schmidt A; Hall A; Roberts JM
Genes Dev; 2004 Apr; 18(8):862-76. PubMed ID: 15078817
[TBL] [Abstract][Full Text] [Related]
13. Difference in the malignancy between RAS and GLI1-transformed astrocytes is associated with frequency of p27
Sasai K; Tabu K; Saito T; Matsuba Y; Saido TC; Tanaka S
Pathol Res Pract; 2021 Jul; 223():153465. PubMed ID: 33989885
[TBL] [Abstract][Full Text] [Related]
14. The role of p27(Kip1) phosphorylation at serine 10 in the migration of malignant glioma cells in vitro.
Wang D; He F; Zhang L; Zhang F; Wang Q; Qian X; Pan X; Meng J; Peng C; Shen A; Chen J
Neoplasma; 2011; 58(1):65-73. PubMed ID: 21067268
[TBL] [Abstract][Full Text] [Related]
15. p27 deficiency is associated with migration defects in PDGF-expressing gliomas in vivo.
See WL; Heinberg AR; Holland EC; Resh MD
Cell Cycle; 2010 Apr; 9(8):1562-7. PubMed ID: 20404478
[TBL] [Abstract][Full Text] [Related]
16. Plexin-B1 indirectly affects glioma invasiveness and angiogenesis by regulating the RhoA/αvβ3 signaling pathway and SRPK1.
Chang Y; Li L; Zhang L; Guo X; Feng Z; Zhou J; Zhou S; Feng G; Han F; Huang W; Yang J; Huang F
Tumour Biol; 2016 Aug; 37(8):11225-36. PubMed ID: 26944058
[TBL] [Abstract][Full Text] [Related]
17. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc.
Kim EJ; Kim SH; Jin X; Jin X; Kim H
Cell Death Differ; 2017 Apr; 24(4):649-659. PubMed ID: 28060381
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival.
Ermoian RP; Furniss CS; Lamborn KR; Basila D; Berger MS; Gottschalk AR; Nicholas MK; Stokoe D; Haas-Kogan DA
Clin Cancer Res; 2002 May; 8(5):1100-6. PubMed ID: 12006525
[TBL] [Abstract][Full Text] [Related]
19. RhoA-mediated inhibition of vascular endothelial cell mobility: positive feedback through reduced cytosolic p21 and p27.
Hsu YH; Chang CC; Yang NJ; Lee YH; Juan SH
J Cell Physiol; 2014 Oct; 229(10):1455-65. PubMed ID: 24535918
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.
Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S
Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
